Oncology

New research shows significant differences in gut microbiota diversity and composition in postmenopausal breast cancer patients compared with controls.

A prospective study shows reduced vaccine protection after chimeric antigen receptor T cell therapy, with pre-vaccination B cell count predicting immune response.

A validated nomogram predicts survival in solid pseudopapillary neoplasm, showing strong accuracy and clinical utility across training, validation, and external cohorts.

Targeted MRI accurately assesses new bone pain in stable multiple myeloma, guiding management and reducing unnecessary whole-body scans.

Oestrogen and environmental exposures drive DNA damage in BRCA1 mutation cells, while Indole-3 carbinol shows promise in reducing genomic instability.

Greater fitness and healthier body composition are linked to improved chemotherapy tolerance in breast cancer, with limited impact on treatment response.

AI driven MRI analysis improves detection of clinically significant prostate cancer, offering higher diagnostic accuracy than traditional approaches.

The International Agency for Research on Cancer has revealed the structural and social barriers stopping people from adopting cancer preventive behaviours in the EU.